GlassScriptPhysician profile
Fredelito B Tiu
NPI 1346240843
$5,664.06
in general payments reported to CMS, 2019-2025
35 companies · $2,362 in 2025
The $2,362 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $117 · 2021: $97.70 · 2022: $162 · 2023: $617 · 2024: $1,667 · 2025: $2,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,645.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,218.21 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $739.62 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $493.80 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $492.64 | 2022-2025 | |
| Abbvie INC. | $454.11 | 2024-2025 | |
| Amgen INC. | $375.55 | 2019-2025 | Repatha, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $247.96 | 2023-2025 | |
| Lilly USA, LLC | $217.90 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.85 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $163.34 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Phathom Pharmaceuticals, INC. | $131.71 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $123.42 | 2019-2020 | |
| Abbott Laboratories | $85.54 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.35 | 2019-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $59.06 | 2025 | Veozah |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $58.32 | 2024-2025 | |
| Exact Sciences Corporation | $48.88 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amarin Pharma, INC. | $48.61 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $48.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $47.33 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.39 | 2025 | Caplyta |
| Tactile Systems Technology INC | $36.97 | 2025 | Flexitouch Plus, Nimbl |
| Esperion Therapeutics, INC. | $30.76 | 2021-2025 | Nexletol |
| Amneal Pharmaceuticals LLC | $30.61 | 2024 | Unithroid, Rytary |
| Edwards Lifesciences Corporation | $24.56 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Nevro Corp. | $21.18 | 2024 | Senza |
| Soleno Therapeutics, INC. | $20.98 | 2025 | Vykat Xr |
| Axsome Therapeutics, INC. | $20.51 | 2025 | Auvelity |
| Globus Medical, INC. | $17.82 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $17.60 | 2025 | Zoryve |
| Scilex Pharmaceuticals INC. | $16.96 | 2024 | |
| Azurity Pharmaceuticals, INC. | $16.85 | 2023 | Edarbi |
| Teleflex LLC | $16.76 | 2025 | Barrigel |
| Averitas Pharma INC. | $16.32 | 2024 | Qutenza |
| Sanofi Pasteur INC. | $13.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredelito Tiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.